Unknown Author
January 24, 2026
Kirkland Advises Nordic-backed ArisGlobal on Acquisition of Amplexor Life Sciences

1 min
AI-made summary
- Kirkland & Ellis advised ArisGlobal, a portfolio company of Nordic Capital, on its acquisition of Amplexor Life Sciences, a company specializing in regulatory process, compliance, and operational excellence for the life sciences sector
- The Kirkland team included corporate, technology and IP transactions, tax, and antitrust partners and associates, led by corporate partners Louis Gosset and Vincent Ponsonnaille, with support from several other named team members.
Kirkland & Ellis advised ArisGlobal, a portfolio company of Nordic Capital, on the acquisition of Amplexor Life Sciences, a life sciences organization focused on end-to-end regulatory process, compliance and operational excellence. Read ArisGlobal’s press release The Kirkland team was led by corporate partners Louis Gosset and Vincent Ponsonnaille, with support from corporate partners Constantine Skarvelis and Abhishek Kolay and associates Etienne Vautier, Sandra Lewitz and Kimberly Guo; technology & IP transactions partner John Patten and associates Ben Zeris and Lana Khoury; tax partners Sonia Bouaffassa and Vivek Ratnam; and antitrust partners Paula Riedel and Thomas Wilson and associate Alexandre Rouhette.
Article Author
Unknown Author
The Sponsor
